Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering
Samuel Davis(Regeneron (United States)), George D. Yancopoulos(Regeneron (United States)), Thomas H. Aldrich(Regeneron (United States)), Jim Fandl(Regeneron (United States)), Tammy Huang(Regeneron (United States)), Ľubomír Kováč(Regeneron (United States)), Raymond Leidich(Regeneron (United States)), Vivek Jain(Regeneron (United States)), Thomas J. Daly(Regeneron (United States)), Steven J. Samuelsson(Procter & Gamble (United States)), Margaret Karow(Regeneron (United States)), Peter C. Maisonpierre(Regeneron (United States)), April Xu(Regeneron (United States)), Ella Ioffe(Regeneron (United States)), Judah Goldberg(Regeneron (United States)), Elzbieta Radziejewska(Regeneron (United States)), Kevin M. Bailey(Regeneron (United States)), Czeslaw Radziejewski(Regeneron (United States)), John S. Rudge(MedStar Washington Hospital Center), Ashique Rafique(Regeneron (United States))
Cited by 232
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k
Angiopoietin-1 protects the adult vasculature against plasma leakage
|Nature Medicine|2000|1.3k
Evinacumab for Homozygous Familial Hypercholesterolemia
|New England Journal of Medicine|2020|763